Literature DB >> 3001133

Immunoradiometric assay of a recombinant human alpha-2 interferon (SCH 30500).

W P Protzman, M Minnicozzi, S L Jacobs, D I Surprenant, J Schwartz, E M Oden.   

Abstract

A sensitive immunoradiometric assay for recombinant alpha-2 interferon (IFN-alpha 2; SCH 30500) was developed by using the monoclonal antibody NK2. A polystyrene bead with polyclonal sheep anti-human IFN-alpha (Hu IFN-alpha) antibody adsorbed to it formed the solid phase of the assay. The monoclonal antibody, labeled with 125I, reacted with the IFN-alpha 2 which bound to the polyclonal antibody on the bead. The assay was sensitive, capable of measuring less than 5 IU/ml, and it was precise. Coefficients of variation were less than 10%, often less than 5%. Interassay coefficients of variation for the same sample were also less than 10%. Specificity of the monoclonal antibody for IFN-alpha 2 was greater than for Hu IFN-alpha produced by leukocytes. In specificity studies it was necessary to add at least 200 IU of Hu IFN-alpha per ml to 25 IU of IFN-alpha 2 per ml before the Hu IFN-alpha affected the accuracy of the assay of IFN-alpha 2. Accuracy as determined by correlation studies with the antiviral cytopathic effect assay was very high. Results of the two assays usually agreed within 15%. This correlation was maintained in studies of IFN-alpha 2 after storage under accelerated degradation conditions, when the IFN was cleaved into smaller sequences of amino acids by cyanogen bromide and when the IFN was carboxymethylated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001133      PMCID: PMC268474          DOI: 10.1128/jcm.22.4.596-599.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins.

Authors:  A M CRESTFIELD; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

2.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

3.  A rapid and simple method for assaying interferon.

Authors:  J Suzuki; T Akaboshi; S Kobayashi
Journal:  Jpn J Microbiol       Date:  1974-11

4.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

5.  Immunoradiometric assay of human leukocyte interferon using monoclonal antibody.

Authors:  D S Secher
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  The reaction of the anti-interferon-alpha monoclonal antibody, NK2, with different interferons.

Authors:  J T Whittall; R M King; D C Burke
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

7.  Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.

Authors:  H Ozer; M Gavigan; J O'Malley; D Thompson; B Dadey; A Nussbaum-Blumenson; C Snider; S Rudnick; R Ferraresi; S Norred
Journal:  J Biol Response Mod       Date:  1983

8.  Analysis and purification of human lymphoblastoid (Namalwa) interferon using a monoclonal antibody.

Authors:  G Allen; K H Fantes; D C Burke; J Morser
Journal:  J Gen Virol       Date:  1982-11       Impact factor: 3.891

9.  At least three human type alpha interferons: structure of alpha 2.

Authors:  M Streuli; S Nagata; C Weissmann
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

10.  Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.

Authors:  F G Hayden; J M Gwaltney
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

View more
  1 in total

Review 1.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.